Westpac Banking Corp’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
– Sell
-60,815
Closed -$7.6M – 839
2021
Q3
$7.6M Sell
60,815
-2,900
-5% -$345K 0.08% 314
2021
Q2
$7.91M Buy
63,715
+21,900
+52% +$2.95M 0.08% 319
2021
Q1
$6.38M Sell
41,815
-12,696
-23% -$1.92M 0.07% 349
2020
Q4
$7.03M Buy
+54,511
New +$6.27M 0.08% 316

Other funds holding GH

Westpac Banking Corp's GH Position: Q4 2021 in Review

Westpac Banking Corp sold out of Guardant Health (GH) in Q4 2021, closing a stake of 60,815 shares — an estimated $7.6M sold.

Westpac Banking Corp first reported a position in GH in Q4 2020 and held it in 4 quarters. The position peaked at $7.91M in Q2 2021. 396 funds tracked by Wall St. Rank hold GH as of Q4 2021.

  • Westpac Banking Corp reported no remaining Guardant Health position as of Q4 2021 after selling out during the quarter.
  • Westpac Banking Corp sold 60,815 Guardant Health shares in Q4 2021, an estimated $7.6M.
  • Westpac Banking Corp first reported a position in Guardant Health in Q4 2020 and held it in 4 quarters.
  • Westpac Banking Corp's Guardant Health position peaked at $7.91M in Q2 2021.
  • 396 funds tracked by Wall St. Rank held Guardant Health as of Q4 2021.

Based on Westpac Banking Corp's 13F filing for Q4 2021, filed 8 Feb 2022.